Clinical Trial: Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma

Sponsor and Collaborators
Sidney Kimmel Comprehensive Cancer Center

Contact
Contact: Ivan Borrello, MD
410-955-4967
[email protected]


Continue Reading

Principal Investigator
Ivan Borrello, MD

ClinicalTrials.gov Identifier
NCT01045460